http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102250240-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f13cf218290cd7ba68bfd995a19364d1 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-065 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-18 |
| filingDate | 2011-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b963643fb1dd9a59f9abd8ed4016944 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c35baf1d2550390983f6ed9e1221da4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_905b1da423b8ab91648d9dfc439938dc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_78823750bb8696ea3e4b7a4081066b3a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f71486fc32674d2ef04023973fc8ae7b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ebe6e4b5fdd0065859ce34fd93b0d44a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1eba78a0f28afb067e1816ce36c698c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56e5bfd9f4509a5d28d765d09c5b7838 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f24ddb22b7f33c652e15f07992541f56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fcf547841251ab0d548c71f03bd9471c |
| publicationDate | 2013-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102250240-B |
| titleOfInvention | Method for purifying human immunoglobulin from separated component I+III of blood plasma |
| abstract | The invention relates to a method for separating and purifying human immunoglobulin from a component I+III of blood plasma, and aims to provide a high-efficiency method for recovering high-purity human immunoglobulin. According to the technical scheme provided by the invention, the method comprises the following steps of: a, fully dissolving component I+III precipitate; b, precipitating with octylic acid and removing lipid and a part of impurity protein to prepare IgG (Immunoglobulin G); c, purifying through anion exchange column chromatography; and d, collecting flow-through liquid, performing membrane nanofiltration, ultrafiltration and concentration, preparing the human immunoglobulin, sterilizing and packaging. The method has the beneficial effects of capability of being operated at the room temperature, simple and short steps, high yield, low energy consumption and high output and is suitable for mass production; comprehensive utilization of the blood plasma is fully realized; the time of the entire production process is shortened; the cost is reduced; extremely considerable economic benefit can be produced; the safety of a product is guaranteed by using two virus inactivation/elimination methods of different mechanisms; the environmental pollution is avoided; and the method has high economic and social values. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013172536-A1 |
| priorityDate | 2011-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 43.